怀孕期间的糖尿病和使用长效和超长效胰岛素治疗的重大新进展
相关实验视频
Updated: Sep 9, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Rosa F Drummond1, Karl E Seif1, Arielle J Higgs1
1Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine and Medical Center, Baltimore, Maryland.
在怀孕期间达到高血糖是预防不良后果的关键. 每周一次的基础胰岛素有望改善粘附性和血糖控制.
科学领域:
- 内分泌学
- 妇产科
- 药理学
背景情况:
- 孕期糖尿病影响1-2%的孕妇,需要仔细的血糖控制.
- 由于低血糖风险和复杂的治疗方案,胰岛素治疗是必不可少的,但具有挑战性.
- 目前的基底胰岛素如格拉和德泰米尔是常见的,但新的类似物正在出现.
研究的目的:
- 审查在怀孕期间使用insulin degludec的证据.
- 在怀孕期间研究每周一次基础胰岛素治疗方案的潜在好处和缺点.
主要方法:
- 在怀孕期间对胰岛素降解剂和超长效基底胰岛素的文献综述.
- 对药动力学概况和临床试验数据的分析.
主要成果:
- 在怀孕期间,insulin degludec的疗效与insulin detemir相同.
- 每天服用一次的胰岛素降糖可以简化治疗方案,但不会增加低血糖的风险.
- 每周一次的基础胰岛素方案正在研究潜在的坚持和控制益处.
结论:
- 在怀孕期间,胰岛素降糖是一种可行的基础胰岛素治疗方案.
- 超长效的基础胰岛素,特别是每周一次的配方,可为怀孕期间的糖尿病治疗提供显著的优势.
- 需要对每周一次的基础胰岛素进行进一步的研究,以评估其在孕妇群体中的安全性和有效性.
更多相关视频
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...